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METHODOLOGY

Open Access

Pre-amplification methods for tracking low-grade
Plasmodium falciparum populations during
scaled-up interventions in Southern Zambia
Sungano Mharakurwa1,2†, Rachel Daniels3,4†, Alan Scott2, Dyann F Wirth3,4, Philip Thuma1 and Sarah K Volkman3,4,5*

Abstract
Background: Malaria is receding in many endemic countries with intervention scale -up against the disease.
However, this resilient scourge may persist in low-grade submicroscopic infections among semi-immune members
of the population, and be poised for possible resurgence, creating challenges for detection and assessment of
intervention impact. Parasite genotyping methods, such as the molecular barcode, can identify specific malaria
parasite types being transmitted and allow tracking and evaluation of parasite population structure changes as
interventions are applied. This current study demonstrates application of pre-amplification methods for successful
detection and genotyping of residual Plasmodium falciparum infections during a dramatic malarial decline.
Methods: The study was a prospective cross-sectional design and based on a 2,000 sq km vicinity of Macha Mission
Hospital in southern Zambia. Willing and predominantly asymptomatic residents of all ages were screened for
malaria by microscopy during the 2005 and 2008 transmission seasons, with simultaneous collection of dried blood
spots (DBS) on filter paper, and extraction of Plasmodium falciparum DNA was performed. Plasmodium falciparum
infections were genotyped using a 24 SNP-based molecular barcode assay using real-time PCR. Submicroscopic
parasitaemia samples were subjected to pre-amplification using TaqMan PreAmp Master Mix following the
manufacturer’s instructions before SNP barcode analysis.
Results: There was a dramatic decline of malaria between 2005 and 2008, and the geometric mean parasite
density (95% CI) fell from 704/μL (390–1,271) in 2005 to 39/μL (23–68) in 2008, culminating in a large proportion of
submicroscopic infections of which 90% failed to yield ample DNA for standard molecular characterization among
2008 samples. Pre-amplification enabled successful detection and genotyping of 74% of these low-grade reservoir
infections, overall, compared to 54% that were detectable before pre-amplification (p <0.0005, n = 84). Furthermore,
nine samples negative for parasites by microscopy and standard quantitative PCR amplification were positive after
pre-amplification.
Conclusions: Pre-amplification allows analysis of an otherwise undetectable parasite population and may be
instrumental for parasites identification, tracking and assessing the impact of interventions on parasite populations
during malaria control and elimination programmes when parasitaemia is expected to decline to submicroscopic
levels.
Keywords: Plasmodium falciparum, Genotyping, Pre-amplification, Asymptomatic, Rapid diagnostic test, Diagnostics,
Southern Africa, Zambia
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Background
Through support from the WHO Global Fund Rollback
Malaria (RBM) programme, the President’s Malaria Initiative (PMI), Malaria Control and Evaluation Partnership
(MACEPA) and other public-private partnerships, endemic
countries are scaling up effective interventions against malaria [1-4]. Declines in the malaria burden have since been
reported throughout sub-Saharan Africa [4]. Many countries, especially those situated towards the natural fringes
of malaria transmission, such as the southern African region, are aiming for possible elimination of the disease.
However, the malaria decline has not been universal,
both between and within countries [5], posing risks of
resurgence from this formidably resilient disease. Tracking changes in parasite population structure as it invariably adapts to interventions is not only instrumental in
validating the impact of interventions on silent and nonsilent reservoirs, but also in devising strategies for better
targeting the scourge until its eventual elimination. As
the parasite is brought under control, one of its adaptive
strategies is to persist as silent low-grade carriage.
Harboured in semi-immune members of the community,
the predominantly submicroscopic infections evade not
only detection but also treatment, while presumably capitalizing on the opportunity for genomic adaptation to
overcome interventions. This asymptomatic reservoir is
believed to contribute to new infections and will need
to be identified and addressed for malaria elimination
to occur. The present study applies a pre-amplification
technique and demonstrates its utility for enhanced molecular detection and tracking of recalcitrant Plasmodium
falciparum populations during scaled up interventions.
Methods
Study area and population

The study was based in a 2,000 sq km vicinity of the
Malaria Institute at Macha (MIAM). This area is intrinsically hyperendemic for malaria and is transitioning to
hypoendemicity under scaled up interventions against
the disease. The resident population comprises essentially stable subsistence farming communities of the
Batonga tribe. Ethical approval was obtained for the use
of these samples for parasite genotypic analysis.
Study design

The study consisted of prospective cross-sectional field
surveys for malaria from 2005 and 2008. Surveys were conducted in villages that were selected by simple random
procedure each year, with individuals of all ages assembling
at pre-arranged meeting points for malaria screening.
Data and sample collection

Malaria screening was conducted by microscopy (2005
and 2008) or rapid diagnostic test (RDT, ICT Diagnostics
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South Africa, 2008 only, Figure 1). Microscopy included
thick and thin blood film analysis performed later at the
MIAM laboratory each screening day or the following
morning. All individuals found positive by RDT (in 2008)
or later by microscopy (in 2005 and 2008) were treated
using artemether-lumefantrine following national guidelines, irrespective of whether or not they had symptoms.
Dry blood spots (DBS) were collected on filter paper from
all patients for subsequent parasite genotyping analysis.

Sample pre-amplification

Plasmodium falciparum DNA was extracted from DBS
samples using the Promega DNA IQ Casework Pro Kit
for Maxwell 16 (Promega Corp., Madison, WI, USA) following the manufacturer’s instructions. Real-time DNA
quantification was performed on resultant sample extracts
to determine DNA content, as described by Daniels et al.
[6]. Briefly, 3 μL of each extracted sample was used to determine the parasite template concentration in triplicate
using a TaqMan assay designed to amplify PF3D7_0718800
(formerly PF07_0076), a single-copy conserved protein
with unknown function. Lab-adapted P. falciparum strains
were used as standards in the quantitative real-time reaction with a total reaction volume of 5 μL.
The P. falciparum infection samples from 2005 and
2008 were subjected to polymorphic analysis using a 24
SNP-based parasite molecular barcode assay on an ABI
7900 real-time PCR system, also as described by Daniels
et al. [6]. The molecular barcode is a set of 24 SNP
genotyping assays selected from across the P. falciparum
genome to be selectively neutral; concatenating the genotypes from these independent assays generates what is
known as the molecular barcode. Samples from low-grade
infections, which gave DNA concentrations below the detectable threshold for the barcode assay (0.005 ng/μL),
were subjected to pre-amplification (PreAmp Master Mix,
Life Technologies, Inc, Grand Island, NY, USA) to enhance the template concentration specifically in the regions interrogated by the molecular barcode, following
the manufacturer’s instructions. Pre-amplification reactions comprised 5 μL template DNA extract, 1X TaqMan assay mixture containing 0.2x TaqMan barcoding
and quantification primers, and 1X Preamp master mix
in 20 μL total volumes. Following pre-amplification,
samples were re-quantified as described above.
Several other master mixes were also evaluated to determine which offered the best performance, testing a
master mix from another vendor (Roche cDNA Pre-Amp
Master, Roche Applied Science, Mannheim, Germany)
and a standard genotyping master mix (Life Technologies
TaqMan Universal PCR Master Mix, No AmpErase UNG)
under the same pre-amplification thermal cycler conditions described above.
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Screening by microscopy (2005 and 2008)

Positive
(53)

Negative
(1306)

Random sampling
(31)

Real-time PCR Quantitation
(84)

Positive [ 0.005 ng/uL]
(11)

Negative [ 0.005 ng/uL]
(73)

Real-time PCR
Quantitation

Positive
(50)

Negative
(23)

Molecular barcode assay

Figure 1 Flowchart of samples collected, processed and analyzed for this study using the molecular barcode assay.

Data analysis

Differences in DNA yields from field DBS extracts for
protocols with and without pre-amplification were tested
using McNemar’s Chi-square and the paired t-test for
quantitative data. Temporal changes in parasitaemia and
demographic profiles were examined using Student’s
t-test and Mantel-Haenzel’s Chi-square, respectively.

Results
Background characteristics

There were no significant differences in human demographic characteristics for field samples from 2005
and 2008. However, P. falciparum infections exhibited

substantially lower parasite densities in 2008 compared to 2005 (Table 1). All samples were from asymptomatic carriers in the resident population.
Plasmodium falciparum DNA yields from field samples
with and without pre-amplification

With declining parasite densities between 2005 and 2008,
an increasing proportion of samples could not be directly
genotyped after extraction since yields of P. falciparum
DNA concentrations fell below the 0.005 ng/uL threshold
[6] for reliable barcode assay analysis (Table 2). This constraint was severe among samples from 2008 as compared
to 2005, with both lower average DNA concentration, and
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Table 1 Parasite densities from Plasmodium falciparum
samples and corresponding host characteristics
2005

2008

704

39

[95% CI]

[390–1,271]

[23–68]

Parasite density (/μL) range

35–48,569

8–171

36.4

36.6

36.2–36.6

[36.3–36.8]

9

13

[95% CI]

[8.2–10.7]

[5.0–21.9]

Males (%)

52

27

GMPD (/μL)

Mean axillary temperature (°C)
[95% CI]
Mean age (years)

< 0.0005

0.239

0.08

Detection thresholds

The limits of detection for this pre-amplification approach were determined using serial dilution of standard
DNA samples. Pre-amplification of samples resulted in
reliable barcode data among samples containing as low
Table 2 DNA yield from standard extraction among 2005
and 2008 DBS samples (n = 84)
p-value

Samples with insufficient DNA
79.2% (42/53) 100% (31/31) <0.0005
signal (n)
Mean DNA concentration
(ng/μL) in extracts [95% CI]

0.0003068

0.000042

After
pre-amplification

p-value

Samples with
insufficient
DNA signal (%)

73 (86.9%)

23 (27.3%)

<0.0005

Mean DNA
concentration
(ng/μL) in extracts

0.0001712

0.1301491

[95% CI]

[0.00010890.0002335]

[0.08640780.1738905]

<0.0005

0.138

more specimens yielding no direct DNA signal among
2008 samples (Table 2), consistent with declining parasite
densities (Table 1).
However, application of pre-amplification led to substantially more samples with sufficient DNA concentrations to yield a DNA signal (Table 3). Of the 84 field
samples tested, 53 (63%) were microscopy-positive. Even
among microscopy-positive samples, 30 (35.7% overall)
failed standard qPCR. With pre-amplification, the number of untypable low parasitaemia samples was reduced
to 23 (27.3% overall). Furthermore, of 31 samples negative by RDT or microscopy as well as by qPCR, nine
yielded a molecular barcode after pre-amplification.
Quality control measures (negative no-template controls,
repeated trials with the original sample material and
unique barcode results for the amplified samples) ruled
out cross-contamination to explain this observation. Although all reasonable precautions were taken in the field
and in the laboratory, we cannot completely rule out the
possibility that any of these samples were mis-labeled;
however, our detection threshold experiments indicate
that our observation of molecular barcodes from samples considered to be negative by standard methodologies is likely to be valid.

2008

Before
pre-amplification

p-value

(GMPD, geometric mean parasite density [for positives only, n = 42 and 11,
respectively for 2005 and 2008]; for all samples n = 53 and 31, respectively in
2005 and 2008).

2005

Table 3 DNA yields from dried blood spot field samples
before and after pre-amplification

<0.0005

as 0.00015 ng/μL DNA. Without pre-amplification, the
lowest detectable sample DNA concentration for reliable
barcode detection required 100X greater DNA concentration (0.015 ng/μL) (see Additional files 1 and 2). This
threshold was higher than the 0.005 ng/μL determined
in early studies using an older rotary glass capillarybased real-time PCR machine. Three of nine submicroscopic samples successfully typed after pre-amplification
were also negative by standard nested PCR.
The method of pre-amplification was further evaluated by
testing the performance of an additional pre-amplification
mix from another vendor as well as the standard molecular
barcode genotyping mix under the same pre-amplification
conditions. The Roche cDNA Pre-Amp Master also amplified templates at concentrations lower than the standard
limit of detection for the molecular barcode assay, but had a
higher threshold to produce a complete molecular barcode
compared to the Applied Biosystems product (0.001 ng vs.
0.00015 ng). The standard genotyping master mix did not
improve the product yield compared to both of these preamplification products (see Additional file 3).

Discussion
As malaria recedes under scaled-up interventions applied in endemic countries, the formidable scourge of
malaria is increasingly assuming subpatent infections in
semi-immune, asymptomatic segments of the population
[7]. These submicroscopic infections pose a new challenge, not only as a reservoir for possible resurgence,
but also for detection, documentation and tracking of
intervention impact on the parasite.
The current study shows that the average parasite
density of P. falciparum parasitaemia in the Macha area
of southern Zambia decreased substantially between
2005 and 2008. There was a clear preponderance of submicroscopic, and hence sub-RDT, infections in 2008,
which were much less amenable to detection and genotyping than samples from 2005.
Here the application of a TaqMan pre-amplification
assay demonstrated that this approach significantly increased the proportion of low-parasitaemia field samples
that could undergo molecular genotyping, leading to
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successful analysis of subpatent P. falciparum using a
molecular barcode technique. More work will be required to substantiate the observations reported here,
and to understand the impact of asymptomatic carriage,
for example, on persistent malaria infection and transmission. Although other methodologies, such as nested
PCR, can amplify DNA signals from low-yield samples,
these approaches only allow amplification of one gene at
a time. Pre-amplification, on the other hand, works with
up to 100 short (less than 150 bp) amplicon assays in a
single reaction, thus allowing genotyping of multiple
loci. The amplification conditions, primarily the low
primer concentration, limited number of amplification
cycles, and increased extension time, together reduce
chimera formation and maintain sample integrity. This
strategy is not specific to TaqMan-based assays, and preamplification has been successfully incorporated for used
in gene-specific assays as well as high-resolution melting
assays for drug resistance genotyping [8].
By overcoming the detection challenge posed by these
low-grade silent infections, pre-amplification may aid in
monitoring intervention efficacy, tracking of the last bastions of residual parasites and thwarting potential resurgences during malaria control and elimination programs.
As malaria-endemic regions reduce malaria transmission
and work toward elimination, it will become critical to
have tools and strategies to identify and track asymptomatic carriers, with highly reduced parasitaemia, that
contribute to incident infections.

Conclusions
The TaqMan pre-amplification assay provides a means
for sensitive detection and tracking of residual P.
falciparum infections during malaria control and elimination programmes.
Additional files
Additional file 1: Real-time PCR cycle threshold (Ct) values for
barcode SNPs, at decreasing concentrations of input Plasmodium
falciparum 3D7 DNA, either with or without pre-amplification.
Eight samples (numbered 1 through 8) of 3D7 DNA at variable input
concentrations ranging from 15 to 0.0000015 nanograms (ng) are shown
with or without pre-amplification (PA). Resulting Ct values for each
molecular barcode assay (numbered 1 through 24) are shown with UD
(undetermined) indicating that a Ct value could not be determined due
to low amplicon signal.
Additional file 2: Genotyping results for barcode SNPs, at
decreasing concentrations of input Plasmodium falciparum 3D7
DNA, either with or without pre-amplification. Eight samples
(numbered 1 through 8) of 3D7 DNA at variable input concentrations
ranging from 15 to 0.0000015 nanograms (ng) are shown with or without
pre-amplification (preamp). Resulting calls for each molecular barcode
assay (identified by SNP assay chromosome and coordinate) are shown
with a “dash” (−) indicating that the genotyping call could not be
determined for that assay. “Blank” indicates a no template control.
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Additional file 3: Genotyping results from alternative preamplification kits. Amplification of the 24 molecular barcode assays
(identified by chromosome and coordinate number) from control
samples (amplified using TaqMan Universal PCR Master Mix, no AmpErase
UNG) or Roche samples (amplified using the Roche Realtime Ready preamp Master Mix) at various concentrations of input 3D7 P. falciparum
DNA ranging from 1 to 0.0001 nanograms (ng). A “dash” (−) indicates that
the genotyping call could not be determined for that assay.
Abbreviations
DBS: Dried blood spot; DNA: Deoxyribo nucleic acid; LEV: Low elution
volume; PCR: Polymerase chain reaction; SNP: Single nucleotide
polymorphism; ABI: Applied Bioystems Inc; CI: Confidence interval; RBM: Roll
Back Malaria; PMI: US President’s Malaria Initiative; MACEPA: Malaria Control
and Evaluation Partnership; MIAM: Malaria Institute at Macha; RDT: Rapid
diagnostic test; qPCR: quantitative PCR; bp: base pair; GMPD: Geometric
mean parasite density.
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